Provided by Tiger Fintech (Singapore) Pte. Ltd.

IceCure Medical Ltd.

0.7082
+0.00040.06%
Volume:130.71K
Turnover:92.42K
Market Cap:48.65M
PE:-2.55
High:0.7150
Open:0.7100
Low:0.7000
Close:0.7078
52wk High:1.66
52wk Low:0.5600
Shares:68.70M
Float Shares:40.78M
Volume Ratio:0.62
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2781
EPS(LYR):-0.3011
ROE:-230.80%
ROA:-76.40%
PB:16.83
PE(LYR):-2.35

Loading ...

IceCure Medical Ltd. to Report Third Quarter 2025 Results

Reuters
·
Nov 12

IceCure Medical Promotes Shay Levav to Chief Operating Officer

Reuters
·
Nov 10

Icecure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction

THOMSON REUTERS
·
Nov 10

IceCure Medical Showcases FDA-Authorized ProSense Device for Minimally Invasive Breast Cancer Treatment

Reuters
·
Nov 04

IceCure Cryoablation System Shows 74% Five-Year Survival in Stage I Lung Cancer Study

Reuters
·
Nov 03

Icecure Medical Ltd expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Oct 31

IceCure Medical Announces Termination of VP of Operations and Services, Effective January 2026

Reuters
·
Oct 17

Investors push IceCure Medical (NASDAQ:ICCM) 13% lower this week, company's increasing losses might be to blame

Simply Wall St.
·
Oct 13

IceCure Medical Ltd publishes presentation on FDA authorized ProSense cryoablation device for minimally invasive breast cancer treatment

Reuters
·
Oct 09

Buy Rating for Icecure Medical: FDA Approval and Strategic Initiatives Drive Growth Potential

TIPRANKS
·
Oct 08

IceCure Medical Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Oct 07

IceCure Medical price target raised to $2.50 from $2 at H.C. Wainwright

TIPRANKS
·
Oct 07

Icecure Medical Ltd : H.c. Wainwright Raises Target Price to $2.5 From $2

THOMSON REUTERS
·
Oct 07

IceCure Medical Receives FDA Marketing Authorization for ProSense® Cryoablation System to Treat Early-Stage Breast Cancer in Elderly Patients

Reuters
·
Oct 04

Icecure Medical Ltd trading halted, news pending

TIPRANKS
·
Oct 03

IceCure Medical Showcases ProSense® Success at EUSOBI Congress 2025

TIPRANKS
·
Sep 30

IceCure Medical Showcases Positive Results for ProSense® Cryoablation in Early-Stage Breast Cancer at EUSOBI 2025, Highlighting Growing Momentum for Minimally Invasive Treatment

Reuters
·
Sep 30

IceCure Medical Showcases ProSense® Success at CIRSE 2025

TIPRANKS
·
Sep 22

IceCure Medical Ltd. Showcases ProSense® Cryoablation Technology at CIRSE Annual Meeting

Reuters
·
Sep 22

IceCure Medical granted notice of allowance for U.S. patent

TIPRANKS
·
Sep 18